METHODS
This is a descriptive cross-sectional study. Fifty-four patients with HCC who either visited the OPD or were admitted to the TUTH under the Department of Gastroenterology from March 2020 to August 2022 were considered for the study. These patients had at least one clinical, radiological, or biochemical evidence of HCC. We analyzed the risk factors, clinical characteristics, and treatment modalities in patients with HCC. The diagnosis of HCC was made by detailed clinical examination, imaging modality (dynamic CT scan or MRI of the abdomen) which show early arterial enhancement and venous washout of the lesion, or with the biopsy of the lesion whenever necessary. Predetermined proforma was used as a tool for data collection. The study was approved by the Institutional Review Committee of the Institute of Medicine (reference number: 132/ (6-11) E2/076/077).